EVOLOCUMAB | B125522 | AMGEN INC
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 7-Year Orphan | Sep. 24, 2028 | Active | Purple Book |
| 12-Year BPCIA | Aug. 27, 2027 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12433264(manufacturing) · relevance 72/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 313 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.